Average Co-Inventor Count = 4.41
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aragon Pharmaceuticals, Inc. (15 from 34 patents)
2. Genentech, Inc. (11 from 3,222 patents)
3. Merck + Co., Inc. (10 from 4,770 patents)
4. Metacrine, Inc. (8 from 8 patents)
5. Sloan-kettering Institute for Cancer Research (7 from 512 patents)
6. Seragon Pharmaceuticals, Inc. (6 from 6 patents)
7. Merck Sharp + Dohme Corp. (3 from 2,405 patents)
8. Tanabe Seiyaku Company, Limited (2 from 324 patents)
9. Eli Lilly and Company (1 from 4,446 patents)
10. Mitsubishi Tanabe Pharma Corporation (1 from 257 patents)
11. Organovo, Inc. (1 from 31 patents)
12. F. Hoffmann-la Roche Ag (168 patents)
58 patents:
1. 12491160 - Formulations of a farnesoid X receptor agonist
2. 12018008 - Crystalline forms of an androgen receptor modulator
3. 11773094 - Farnesoid X receptor agonists and uses thereof
4. 11236071 - Farnesoid X receptor agonists and uses thereof
5. 11214538 - Farnesoid X receptor agonists and uses thereof
6. 11084817 - Farnesoid X receptor agonists and uses thereof
7. 10961198 - Farnesoid X receptor agonists and uses thereof
8. 10934271 - Crystalline forms of an androgen receptor modulator
9. 10927082 - Farnesoid X receptor agonists and uses thereof
10. 10766875 - Crystalline forms of an androgen receptor modulator
11. 10703712 - Farnesoid X receptor agonists and uses thereof
12. 10626081 - Farnesoid X receptor agonists and uses thereof
13. 10556882 - Crystalline forms of an androgen receptor modulator
14. 10526310 - Crystalline forms of an androgen receptor modulator
15. 10377717 - Farnesoid X receptor agonists and uses thereof